EPA Appoints Pesticide Industry Reps to Science Advisory Board, Sparking Debate Over Regulatory Independence

The Environmental Protection Agency's Science Advisory Board has undergone a significant transformation under Administrator Lee Zeldin, with four new appointments from the chemical and pesticide industries stirring debate about the balance between industry expertise and scientific independence in environmental regulation.

Announced last week, the appointments include Jessica LaRocca of Corteva Agriscience, Matthew LeBaron from Dow Chemical Company, and two representatives from Chemours—Shawn Gannon and Sean Uhl. Gary Minsavage from ExxonMobil's biomedical division also joined the board. These selections mark a notable shift from the previous administration, when only one of 48 appointed members represented the chemical industry.

The Science Advisory Board serves as a critical voice in EPA decision-making, providing independent scientific counsel on everything from toxicological reviews to risk assessment methodologies. At a fall 2024 meeting, members offered feedback on arsenic exposure guidelines and approaches to evaluating risks from multiple chemical exposures simultaneously—work that directly shapes how pesticides and other chemicals are regulated nationwide.

"Reconstituting the Science Advisory Board will provide rigorous, independent, evidence-based, scientific advice consistent with its legal obligations to advance our core mission of protecting human health and the environment," Zeldin stated in a press release announcing the appointments.

For Texas pest control operators and agricultural producers, the composition of this board carries practical weight. The board's recommendations influence which active ingredients remain available for use, how application rates are determined, and what safety protocols are mandated. When the EPA evaluates a new mosquito control product or reviews an existing termiticide's registration, Science Advisory Board input helps shape the outcome.

Corteva Agriscience, represented by LaRocca, ranks among the world's largest agricultural chemical manufacturers, producing insecticides, herbicides, and fungicides used extensively throughout Texas cotton, corn, and sorghum production. Dow Chemical, where LeBaron is employed, produces chemicals used in pesticide formulations despite spinning off its dedicated crop protection business. Chemours, the employer of both Gannon and Uhl, manufactures products containing per- and polyfluoroalkyl substances—PFAS "forever chemicals" that have increasingly drawn regulatory scrutiny after contaminating farm soils and waterways across the country.

The appointments follow last year's dismissal of the board's previous membership, a move environmental organizations criticized as purging independent scientists. Earthjustice and other groups characterized the restructuring as "a dangerous step toward sidelining science in favor of political agendas."

Industry representation on scientific advisory panels isn't unprecedented, nor is it inherently problematic. Manufacturers possess deep technical knowledge about their products' chemistry, efficacy, and application methods that can inform sound regulatory decisions. The question critics raise is whether the current balance tips too far toward industry perspectives at the expense of independent academic research and public health expertise.

Texas agriculture illustrates the stakes. The state's $100 billion agricultural sector relies on pest management tools ranging from traditional synthetic pesticides to emerging biological alternatives. Regulatory decisions made in Washington directly affect what products Texas growers can access, when they can apply them, and how they must document compliance.

The board's 37 other appointees come primarily from academic institutions, maintaining a substantial research presence. But the handful of industry representatives now holds proportionally greater influence than under previous administrations, when Bayer's single representative stood alone among dozens of academic scientists.

For pest management professionals, the practical implications will unfold gradually. The board doesn't set policy directly—that authority remains with EPA administrators—but its recommendations carry substantial weight in rulemaking. When the EPA proposes re-evaluating a widely used active ingredient or establishes new buffer zones around sensitive areas, the Science Advisory Board's scientific assessment often provides the foundation for those decisions.

The appointments also come amid broader debates about pesticide regulation, including ongoing discussions about neonicotinoid impacts on pollinators, glyphosate's classification, and emerging concerns about PFAS contamination in agricultural settings. How the reconstituted board addresses these questions will shape the regulatory landscape for years to come.

Texas producers and pest control operators should monitor the board's upcoming meetings and comment periods. While industry expertise can provide valuable practical insights, the effectiveness of pesticide regulation ultimately depends on scientific assessments that prioritize public health and environmental protection alongside agricultural productivity.

The EPA has not announced specific agenda items for the reconstituted board's first meetings, but stakeholders expect reviews of several pending chemical evaluations and potential updates to risk assessment methodologies to appear early in the schedule.